Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Calliditas Therapeutics AB American Depositary Shares (CALT)

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/05/2020

Market Cap

1,059,752,575

Shares Outstanding

59,580,000

Weighted SO

26,836,035

Total Employees

N/A

Upcoming Earnings

08/15/2024

Similar Tickers

KDNY --.--%

DICE --.--%

PLRX --.--%

CRNX --.--%

ASND --.--%

TVTX --.--%

CYTK --.--%

VTYX --.--%

COGT --.--%

Beta

1.4800

Last Div

0.0000

Range

15.25-41.9

Chg

0.5299

Avg Vol

14983

Mkt Cap

1059752575

Exch

NASDAQ

Country

SE

Phone

46 84 11 30 05

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

6.9351

EV Multiple

-30.7375

P/FV

208.0545

Div Yield %

0.0000

P/E

-46.2524

PEG

-1.2269

Payout

0.0000

Current Ratio

2.6862

Quick Ratio

2.5927

Cash Ratio

1.8551

DSO

50.7326

DIO

140.0445

Op Cycle

190.7771

DPO

526.5617

CCC

-335.7846

Gross Margin

0.9346

Op Margin

-0.2299

Pretax Margin

-0.2924

Net Margin

-0.3000

Eff Tax Rate

-0.0257

ROA

-0.2749

ROE

-2.1018

ROCE

-0.2795

NI/EBT

1.0257

EBT/EBIT

1.2720

EBIT/Rev

-0.2299

Debt Ratio

0.5623

D/E

9.2003

LT Debt/Cap

0.9020

Total Debt/Cap

0.9020

Int Coverage

-3.1964

CF/Debt

-0.2493

Equity Multi

16.3613

Rec Turnover

7.1946

Pay Turnover

0.6932

Inv Turnover

2.6063

FA Turnover

26.9798

Asset Turnover

0.9166

OCF/Share

-4.5622

FCF/Share

-4.8004

Cash/Share

14.8505

OCF/Sales

-0.1529

FCF/OCF

1.0522

CF Coverage

-0.2493

ST Coverage

0.0000

CapEx Coverage

-19.1533

Div&CapEx Cov

-19.1533

P/BV

208.0545

P/B

208.0545

P/S

6.9351

P/E

-46.2524

P/FCF

-43.0928

P/OCF

-90.7106

P/CF

-90.7106

PEG

-1.2269

P/S

6.9351

EV Multiple

-30.7375

P/FV

208.0545

DPS

0.0000

Latest Headlines (EST)

MarketWatch Dec 21, 06:38 It's time to take profits, says strategist with top S&P 500 target for next year

Revenue Product Segmentation